FILE PHOTO: Werner Baumann, CEO of Bayer AG, attends the German drugmaker’s annual results news conference in Leverkusen, Germany, February 27, 2020. REUTERS/Wolfgang Rattay/File Photo
FILE PHOTO: Werner Baumann, CEO of Bayer AG, attends the German drugmaker’s annual results news conference in Leverkusen, Germany, February 27, 2020. REUTERS/Wolfgang Rattay/File Photo